Efficacy difference between rehabilitation therapy and umbilical cord derived mesenchymal stem cells transplantation in patients with acute or chronic spinal cord injury
Overview:
This study is being conducted by researchers at the General Hospital
of Chinese Armed Police Forces. 40 patients with traumatic spinal
cord injury (20 cases in the acute stage of injury and 20 in the
later sequela stage) will receive mesenchymal stem cells (MSC’s)
derived from umbilical cord tissue. The study is targeting adult
patients with spinal cord injury between the ages of 20 and 50
years.
The MSC’s from human umbilical cord are transplanted directly by injection (lumbar puncture) into the subarachnoid space in the spine. Investigators also plan to follow up 10 patients who receive only rehabilitation and another 10 patients as a control group who accept neither stem cell therapy nor rehabilitation. On this basis, the researchers can compare the efficacy of these two treatments.
Location: Beijing, China
Trial design: Safety and efficacy
Status: Open
Find out more